On June 28, 2013, CorMedix received notification from TÜV-SÜD, the European notified body managing the CE Mark application for our product candidate CRMD003, or Neutrolin, that the review of the CE Mark for Neutrolin is anticipated to be finalized on or around July 3, 2013, depending on the availability of the applicable agency personnel.
I am OK with that. Neither Pfaffle nor Lefkowitz draw salaries here. Pfaffle has an hourly arrangement and Lefkowitz works for his director's comp. Without them, this company would have been gone 6 months ago. Don't forget to cast your BOD ballots. Vote early, vote often.
I sincerely hope the call is robust. Folks need information as to post-approval path. I suspect they have been laying the marketing groundwork during this never-ending delay.
Yeah right, what is this the second or third time they amended that? At least this time they only moved the date a couple weeks out to July 14th. So this time, fingers crossed, I am pretty confident we will get news next week.